Prescription of Tamoxifen for Breast Cancer Prevention by Primary Care Physicians
- 13 November 2006
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 166 (20) , 2260-2265
- https://doi.org/10.1001/archinte.166.20.2260
Abstract
Research from JAMA Internal Medicine — Prescription of Tamoxifen for Breast Cancer Prevention by Primary Care PhysiciansThis publication has 19 references indexed in Scilit:
- Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 2005
- Tamoxifen For Breast Cancer Chemoprevention: Low Uptake by High-Risk Women After Evaluation of a Breast LumpAnnals of Family Medicine, 2005
- Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reductionCancer, 2005
- Decision-Making About Tamoxifen in Women at High Risk for Breast Cancer: Clinical and Psychological FactorsJournal of Clinical Oncology, 2004
- Acceptance of tamoxifen chemoprevention by physicians and women at riskCancer, 2004
- Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast CancerJNCI Journal of the National Cancer Institute, 1999
- Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer IncidenceJNCI Journal of the National Cancer Institute, 1999
- Cancer Chemoprevention: Progress and PromiseJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989